Final approval is still a risk, altho' mitigated somewhat by the outstanding clinical results achieved thus far, however I think the main reason we're sitting on our hands is because we're awaiting the outcome of the formal negotiations with one or more global healthcare suppliers....
risks, page-5
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)